C. Stehman-Breen

发表

Cystatin C and the risk of death and cardiovascular events among elderly persons.

D. Siscovick, A. Newman, M. Shlipak, 2005, The New England journal of medicine.

HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients.

B. Kestenbaum, N. Weiss, S. Seliger, 2002, Kidney international.

Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.

C. Stehman-Breen, R. Kilpatrick, C. Critchlow, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis‡

C. Stehman-Breen, C. Critchlow, F. Xue, 2013, Pharmacoepidemiology and drug safety.

Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents*

C. Stehman-Breen, R. Kewalramani, M. Krause, 2009, Current medical research and opinion.

An open‐label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis

C. Stehman-Breen, A. Agarwal, N. Varma, 2006, Journal of internal medicine.

Chronic kidney disease increases risk for venous thromboembolism.

A. Folsom, S. Heckbert, C. Stehman-Breen, 2008, Journal of the American Society of Nephrology : JASN.

Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients.

Craig S. Wong, B. Kestenbaum, S. Seliger, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Calcium channel blocker use and mortality among patients with end-stage renal disease.

B. Kestenbaum, S. Seliger, C. Stehman-Breen, 2002, Kidney international.

Increased risk of preeclampsia among nulliparous pregnant women with idiopathic hematuria.

B. Sibai, C. Stehman-Breen, P. Catalano, 2002, American journal of obstetrics and gynecology.

Increased risk of mortality associated with hip fracture in the dialysis population.

C. Stehman-Breen, D. Gillen, A. Mittalhenkle, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Survival following parathyroidectomy among United States dialysis patients.

B. Kestenbaum, S. Schwartz, S. Seliger, 2004, Kidney international.

Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?

E. Vittinghoff, C. Furberg, N. Wenger, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death

Lorien S. Dalrymple, L. Fried, B. Kestenbaum, 2010, Journal of General Internal Medicine.

Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease

A. Nakanishi, C. Stehman-Breen, B. Warady, 2006, Pediatric Nephrology.

Prescription of hormone replacement therapy in postmenopausal women with renal failure.

C. Stehman-Breen, D. Gipson, D. Gillen, 1999, Kidney international.

Hepatitis C and renal disease: an update.

J. Hoofnagle, C. Stehman-Breen, C. Meyers, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bone Mineral Density Measurements in Dialysis Patients

C. Stehman-Breen, 2001, Seminars in dialysis.

Osteoporosis in chronic kidney disease.

S. Ott, C. Stehman-Breen, M. Leonard, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Focal Segmental Glomerular Sclerosis among Patients Infected with Hepatitis C Virus

C. Alpers, C. Stehman-Breen, Richard J. Johnson, 1999, Nephron.

Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency.

C. Stehman-Breen, S. Coburn, A. Lindner, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Secondary hyperparathyroidism complicated by parathyromatosis.

C. Stehman-Breen, D. Sherrard, N. Muirhead, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pre-Eclampsia and Premature Labour Among Pregnant Women With Haematuria

S. Schwartz, C. Stehman-Breen, J. Fink, 2000 .

Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients.

C. Stehman-Breen, D. Gretch, S. Emerson, 1997, Transplantation.

Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.

C. Stehman-Breen, D. Gillen, D. Sherrard, 2001, Journal of vascular surgery.

Risk factors and mortality associated with calciphylaxis in end-stage renal disease.

C. Stehman-Breen, D. Gillen, J. Stivelman, 2001, Kidney international.

Pathogenesis of hepatitis C virus‐associated glomerulonephritis

C. Alpers, W. Couser, C. Stehman-Breen, 1995 .

Hepatitis C virus-associated glomerulonephritis.

C. Stehman-Breen, D. Gretch, R. Johnson, 1995, Advances in internal medicine.

Risk of hip fracture among dialysis and renal transplant recipients.

B. Kestenbaum, N. Weiss, S. Seliger, 2002, JAMA.

Increased risk of adverse maternal and infant outcomes among women with renal disease.

S. Schwartz, C. Stehman-Breen, J. Fink, 1998, Paediatric and perinatal epidemiology.

Kidney function as a predictor of noncardiovascular mortality.

P. Chaves, D. Siscovick, A. Newman, 2005, Journal of the American Society of Nephrology : JASN.

Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients.

B. Kestenbaum, S. Seliger, C. Stehman-Breen, 2003, Kidney international.

Hepatitis C virus associated membranous glomerulonephritis.

C. Alpers, W. Couser, C. Stehman-Breen, 1995, Clinical nephrology.

Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism.

D. Lacey, C. Stehman-Breen, David A. Martin, 2005, Kidney international.

Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis.

S. Ott, C. Stehman-Breen, A. Kausz, 2003, Kidney international.

Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies.

C. Alpers, C. Stehman-Breen, C. Abrass, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Preventive Care in African American Women with End-Stage Renal Disease

C. Stehman-Breen, D. Gillen, S. Levison, 2008 .

Racial differences in bone mineral density and bone loss among end-stage renal disease patients.

C. Stehman-Breen, D. Sherrard, A. Walker, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.

B. Psaty, D. Siscovick, T. Manolio, 2005, JAMA.

Hepatitis C virus-associated glomerulonephritis.

C. Alpers, C. Stehman-Breen, D. Gretch, 1995, Current opinion in nephrology and hypertension.

SAT0479 Early Findings from Prolia® Post-Marketing Safety Surveillance for Atypical Femoral Fracture, Osteonecrosis of the Jaw, Severe Symptomatic Hypocalcemia, and Anaphylaxis

N. Watts, C. Stehman-Breen, S. Papapoulos, 2014 .

Risk factors for incident stroke among patients with end-stage renal disease.

B. Kestenbaum, S. Seliger, C. Stehman-Breen, 2003, Journal of the American Society of Nephrology : JASN.

Parathyroidectomy rates among United States dialysis patients: 1990-1999.

B. Kestenbaum, N. Weiss, S. Seliger, 2004, Kidney international.

Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

B. Wood, C. Stehman-Breen, V. Broudy, 1998, Transplantation.

Risk of death among chronic dialysis patients infected with hepatitis C virus.

C. Stehman-Breen, D. Gretch, S. Emerson, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Investigating hepatitis C virus heterogeneity in a high prevalence setting using heteroduplex tracking analysis.

C. Stehman-Breen, D. Gretch, J. Wilson, 2001, Journal of virological methods.

The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.

J. Brugarolas, C. Alpers, C. Stehman-Breen, 1999, Kidney international.

Cardiovascular and thromboembolic events following hypertensive pregnancy.

B. Kestenbaum, S. Schwartz, S. Seliger, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The presence of frailty in elderly persons with chronic renal insufficiency.

Bruce M Psaty, Linda P Fried, L. Fried, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cystatin C and subclinical brain infarction.

Anne Newman, Daniel L Gillen, Teri Manolio, 2005, Journal of the American Society of Nephrology : JASN.

Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.

L. Kuller, C. Furberg, M. Shlipak, 2004, Journal of the American Society of Nephrology : JASN.

Association of kidney function with incident hip fracture in older adults.

B. Kestenbaum, D. Siscovick, A. Newman, 2007, Journal of the American Society of Nephrology : JASN.

Increased risk of hip fracture among patients with end-stage renal disease.

Craig S. Wong, S. Heckbert, N. Weiss, 2000, Kidney international.

Osteoporosis and chronic kidney disease.

C. Stehman-Breen, 2004, Seminars in nephrology.

Risk factors for hip fracture among patients with end-stage renal disease.

Craig S. Wong, S. Heckbert, N. Weiss, 2000, Kidney international.

Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study.

D. Siscovick, A. Newman, M. Shlipak, 2004, The American journal of geriatric cardiology.

Association of mild to moderate kidney dysfunction and coronary calcification.

B. Kestenbaum, M. Shlipak, R. Katz, 2008, Journal of the American Society of Nephrology : JASN.

Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease

B. Kestenbaum, B. Psaty, D. Siscovick, 2006, Annals of Internal Medicine.

Kidney function predicts the rate of bone loss in older individuals: the Cardiovascular Health Study.

J. Cauley, D. Siscovick, A. Newman, 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study.

D. Siscovick, A. Newman, M. Shlipak, 2005, Archives of internal medicine.

Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults

L. Fried, B. Psaty, D. Siscovick, 2005, Annals of Internal Medicine.

Cystatin-C and mortality in elderly persons with heart failure.

B. Psaty, D. Siscovick, A. Newman, 2005, Journal of the American College of Cardiology.

Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2008, Annals of Internal Medicine.

Effects of denosumab on fracture and bone mineral density by level of kidney function

S. Cummings, S. Boonen, S. Jamal, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Editorials: Are HMG‐CoA Reductase Inhibitors Underutilized in Dialysis Patients?

S. Seliger, C. Stehman-Breen, 2003, Seminars in dialysis.

Gender and the progression of renal disease

S. Seliger, C. Stehman-Breen, C. Davis, 2001, Current opinion in nephrology and hypertension.

Survival Advantage of Pediatric Recipients of a First Kidney Transplant Among Children Awaiting Kidney Transplantation

Craig S. Wong, C. Stehman-Breen, D. Gillen, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Anthropometric measures and risk of death in children with end-stage renal disease.

Craig S. Wong, C. Stehman-Breen, D. Gipson, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Principles of dialysis: special issues in women.

C. Stehman-Breen, L. Katz, D. Gipson, 1999, Seminars in nephrology.

Determinants of type and timing of initial permanent hemodialysis vascular access.

C. Stehman-Breen, D. Gillen, D. Sherrard, 2000, Kidney international.

Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease.

Craig S. Wong, C. Stehman-Breen, D. Gillen, 2002, Kidney international.

Use of the vascular diagnostic laboratory in improving the success of angioaccess procedures.

C. Stehman-Breen, K. Gibson, T. Kohler, 2001, Seminars in vascular surgery.

Assessment of a policy to reduce placement of prosthetic hemodialysis access.

T. Hatsukami, C. Stehman-Breen, D. Gillen, 2001, Kidney international.

Pre‐eclampsia and premature labour among pregnant women with haematuria

S. Schwartz, C. Stehman-Breen, J. Fink, 2000 .

Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.

S. Solomon, M. Pfeffer, J. McMurray, 2005, American heart journal.

Elevated risk of stroke among patients with end-stage renal disease.

B. Kestenbaum, S. Seliger, C. Stehman-Breen, 2003, Kidney international.

Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study.

L. Kuller, D. Siscovick, A. Fitzpatrick, 2004, Journal of the American Society of Nephrology : JASN.

Kidney function, electrocardiographic findings, and cardiovascular events among older adults.

B. Kestenbaum, D. Siscovick, A. Newman, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease.

C. Stehman-Breen, A. Agarwal, M. Krause, 2008, The American journal of geriatric pharmacotherapy.

Cystatin-C and inflammatory markers in the ambulatory elderly.

L. Fried, B. Psaty, D. Siscovick, 2005, The American journal of medicine.

Observational research databases in renal disease.

M. Shlipak, C. Stehman-Breen, 2005, Journal of the American Society of Nephrology : JASN.

Cardiovascular risk factors and incident acute renal failure in older adults: the cardiovascular health study.

B. Psaty, D. Siscovick, A. Newman, 2008, Clinical journal of the American Society of Nephrology : CJASN.

D. Patrick, C. Stehman-Breen, E. Devine, 2003, Expert review of pharmacoeconomics & outcomes research.

Racial differences in early-onset renal disease among young adults: the coronary artery risk development in young adults (CARDIA) study.

C. Lewis, D. Jacobs, D. Siscovick, 2003, Journal of the American Society of Nephrology : JASN.

Is there a hepatitis C virus-associated membranoproliferative glomerulonephritis?

C. Alpers, C. Stehman-Breen, R. Willson, 1997, American Journal of Kidney Diseases.

The effects of denosumab on bone mineral density (BMD) and fracture by level of renal function

S. Cummings, S. Jamal, C. Stehman-Breen, 2010 .

Bone Mineral Density Measurements in Dialysis Patients

C. Stehman-Breen, Catherine Stehman‐Breen, 2001, Seminars in dialysis.

Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.

C. Stehman-Breen, R. Kilpatrick, C. Critchlow, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Increased risk of mortality associated with hip fracture in the dialysis population.

C. Stehman-Breen, D. Gillen, Anuja Mittalhenkle, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.